Stockreport

Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results, Issues 2021 Financial Guidance and Provides Business Update

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
PDF Worldwide Ocaliva® net sales of $83.3 million and $312.7 million for the fourth quarter and full year 2020, representing 18% and 25% growth over the prior year Interce [Read more]